Advances In The Fight Against Arthritis

One of the most life changing, debilitating and evenThese new agents can limit the symptoms and halt
embarrassing diseases is arthritis. It comes in 100's ofthe progression of inflammatory arthritis to a level that
variations and has effects which can range fromhas been previously possible. Although sometimes
"hardly noticeable" to "totally gross". Sure, there arerisky for complications, the treatments may be
techniques, medicines and various tips to fight thisworthwhile for some.
disease, but there is no known all inclusive cure. AlmostIn early January, scientists at the University of Leeds in
20% of our population, or roughly over 40 millionEngland have identified how atoms move across cell
American citizens report that they have beenmembranes in the human body. This research holds
diagnosed with an arthritic condition. This number ishuge promise for new treatments for inflammatory
projected to increase nearly 25% by the year 2030diseases such as rheumatoid arthritis with the
and beyond. It affects more than 22% of all adults 65discovery of a previously unidentified natural
years of age or older. Despite all of this doom andmechanism that opens ion channels, proteins at the cell
gloom, we are progressing, slowly but surely towardssurface that act as doorways into and out of cells,
this elusive goal of a complete cure. Here is thethrough the naturally occurring protein thioredoxin.
rundown of some of the more exciting, albeitThese channels regulate the flow of ions, electrically
sometimes exotic advances in this fight.charged atoms, across the cell membrane to conduct
A drug called Ritual, put out by Biogenic Idec, hasvarious functions such as timing of the heartbeat, pain
shown promise in a late-stage human clinical trial totransmission and regulation of blood glucose. The
treat rheumatoid arthritis. According to Biogenic, theresearch revealed that thioredoxin's - one of the main
drug performance showed significant response incauses or effects of arthritis, working is different, it
combination with existing treatments withactivates an ion channel by donating electrons to it,
methotrexate. Tests were performed in patients withalmost like a switch. Realizing this, new drugs are being
moderate to server rheumatoid arthritis who hadn'tstudied for mimicking these ion channels effects in
responded to methotrexate on their own. So far, theform of a therapy. Its almost like the body's own
news is positive for Biogen. It gained FDA approval innatural defenses are providing new understanding for
February 2006 to use the drug in combination withfuture treatments for arthritis.
methotrexate in patients with moderate to severeCertainly there is a lot more to be done and
rheumatoid arthritis who didn't achieve benefits fromresearched, but these latest advances are showing
previous therapies. The company is now trying tosignificant promise towards successful treatment of
broaden the market reach for Rituxan.this deadly condition. Science along with a renewed
Molecular biology advances have led to the generationperception of the general population towards health
of a new class of medications called biologicalpreservation via exercise, diet, stress management
response modifiers, which are capable of targetingand attitude are all slowly contributing towards a more
inflammatory cells and mediators of inflammation.effective, albeit not all inclusive, cure.